Neuroscience News logo for mobile.
      Neuroscience News Logo

      Major Step Toward an Alzheimer’s Vaccine

      FeaturedNeurology
      ·January 15, 2013

      A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain’s natural defense mechanisms in mice with Alzheimer’s disease symptoms. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer’s disease and a vaccine to prevent the illness.

      One of the main characteristics of Alzheimer’s disease is the production in the brain of a toxic molecule known as amyloid beta. Microglial cells, the nervous system’s defenders, are unable to eliminate this substance, which forms deposits called senile plaques.

      The team led by Dr. Serge Rivest, professor at Université Laval’s Faculty of Medicine and researcher at the CHU de Québec research center, identified a molecule that stimulates the activity of the brain’s immune cells. The molecule, known as MPL (monophosphoryl lipid A), has been used extensively as a vaccine adjuvant by GSK for many years, and its safety is well established.

      In mice with Alzheimer’s symptoms, weekly injections of MPL over a twelve-week period eliminated up to 80% of senile plaques. In addition, tests measuring the mice’s ability to learn new tasks showed significant improvement in cognitive function over the same period.

      Alzheimer's Disease brain slice vs healthy brain slice.
      A healthy brain slice is shown next to a brain slice with severe Alzheimer’s disease. The image is in the public domain.

      The researchers see two potential uses for MPL. It could be administered by intramuscular injection to people with Alzheimer’s disease to slow the progression of the illness. It could also be incorporated into a vaccine designed to stimulate the production of antibodies against amyloid beta. “The vaccine could be given to people who already have the disease to stimulate their natural immunity,” said Serge Rivest. “It could also be administered as a preventive measure to people with risk factors for Alzheimer’s disease.”

      “When our team started working on Alzheimer’s disease a decade ago, our goal was to develop better treatment for Alzheimer’s patients,” explained Professor Rivest. “With the discovery announced today, I think we’re close to our objective.”

      Notes about this Alzheimer’s disease research

      Contacts: Jean-François Huppé – Université Laval
      Pascale St-Pierre – CHU de Québec
      Source: Université Laval press release
      Image Source: Alzheimer’s disease brain image is available in the public domain. Feel free to use.
      Original Research: Abstract for “Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology” by Jean-Philippe Michaud, Maxime Hallé, Antoine Lampron, Peter Thériault, Paul Préfontaine, Mohammed Filali, Pascale Tribout-Jover, Anne-Marie Lanteigne, Rachel Jodoin, Christopher Cluff, Vincent Brichard, Rémi Palmantier, Anthony Pilorget, Daniel Larocque, and Serge Rivest in Proceedings of the National Academy of Sciences published ahead of print January 15, 2013 doi: 10.1073/pnas.1215165110

      Join our Newsletter
      Thank you for subscribing.
      Something went wrong.
      I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
      Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
      We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
      Tags
      Alzheimer's diseaseamyloid-betabrain researchcogntive declinedementiaHealthmedicinemicrogliamonophosphoryl lipid AMPLneurodegenerative diseasesneuroimmunologyneurology researchneuroscience researchsciencesenile plaquesToll-like receptor 4
      ShareTweetShareShareSubmitEmail
      Neuroscience News
      Neuroscience News posts science research news from labs, universities, hospitals and news departments around the world. Science articles cover neuroscience, psychology, AI, robotics, neurology, brain cancer, mental health, machine learning, autism, Parkinson's, Alzheimer's, brain research, depression and other sciences.

      One Comment

      1. Pingback: Alzheimer: speranze dalla ricerca. « Medicina in Biblioteca

      Comments are closed.

      Neuroscience News Footer Logo
      • Facebook
      • Twitter
      • Instagram
      • YouTube
      • Linkedin

      Neuroscience News Sitemap
      Neuroscience Graduate and Undergraduate Programs
      Free Neuroscience MOOCs
      About
      Contact Us
      Privacy Policy
      Submit Neuroscience News
      Subscribe for Emails

      Neuroscience Research
      Psychology News
      Brain Cancer Research
      Alzheimer’s Disease
      Parkinson’s News
      Autism / ASD News
      Neurotechnology News
      Artificial Intelligence News
      Robotics News

      Search Neuroscience News

      Neuroscience News is an online science magazine offering free to read research articles about neuroscience, neurology, psychology, artificial intelligence, neurotechnology, robotics, deep learning, neurosurgery, mental health and more.

      Neuroscience News
      • Neuroscience
        • Featured
        • Neuroscience Videos
        • Neuro Web Stories
        • Open Access Neuroscience
        • Electrophysiology
        • Genetics
        • Neuroscience Programs
      • Neurology
        • Alzheimer’s Disease
        • Brain Research
        • Brain Cancer
        • Autism
        • Epilepsy
        • Traumatic Brain Injuries
        • Parkinson’s Disease
      • Psychology
        • Schizophrenia
        • Depression
        • Bipolar Disorder
        • Mental Health
      • AI
        • Neural Networks
        • Deep Learning
        • Machine Learning
      • Robotics
      • Neurotech
        • Brain Computer Interfaces
        • Neuroprosthetics
      • About
        • Neuroscience Newsletters
        • Submit Neuroscience News
        • Privacy Policy
        • Neuroscience News Sitemap
        • Contact Neuroscience News
        • Advertise on Neuroscience News
      Neuroscience News Small Logo
      • Neuroscience
        • Featured
        • Neuroscience Videos
        • Neuro Web Stories
        • Open Access Neuroscience
        • Electrophysiology
        • Genetics
        • Neuroscience Programs
      • Neurology
        • Alzheimer’s Disease
        • Brain Research
        • Brain Cancer
        • Autism
        • Epilepsy
        • Traumatic Brain Injuries
        • Parkinson’s Disease
      • Psychology
        • Schizophrenia
        • Depression
        • Bipolar Disorder
        • Mental Health
      • AI
        • Neural Networks
        • Deep Learning
        • Machine Learning
      • Robotics
      • Neurotech
        • Brain Computer Interfaces
        • Neuroprosthetics
      • About
        • Neuroscience Newsletters
        • Submit Neuroscience News
        • Privacy Policy
        • Neuroscience News Sitemap
        • Contact Neuroscience News
        • Advertise on Neuroscience News
      Neuroscience News LogoNeuroscience News
      This shows an older man sleeping.

      Circadian Rhythm Off Beat: Parkinson’s and Nighttime Neuron Damage

      This shows a woman using a laptop.

      ChatGPT’s Role in Shaping Identity and Personal Narratives

      This shows a woman surrounded by speech bubbles.

      New Brain Structures in Language Processing Identified

      This shows a lonely man and a shadowy figure.

      Loneliness Merges Real and Fictional Friends in the Brain

      Start typing to see results or hit ESC to close
      Neuroscience neurobiology brain research Psychology Neurology
      See all results

      Subscribe

      Neuroscience News Daily Emails
      Go to Appearance > Customize > Subscribe Pop-up to set this up.